Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2014, Article ID 946209, 11 pages
http://dx.doi.org/10.1155/2014/946209
Clinical Study

Enhanced Apoptosis of Monocytes from Complication-Free Juvenile-Onset Diabetes Mellitus Type 1 May Be Ameliorated by TNF-α Inhibitors

1Department of Immunology, Medical University of Gdańsk, Ulica Dębinki 1, 80-211 Gdańsk, Poland
2Academic Clinic of Pediatrics, Hematology, Oncology and Endocrinology, Medical University of Gdańsk, Ulica Dębinki 7, 80-211 Gdańsk, Poland
3Department of Family Medicine, Medical University of Gdańsk, Ulica Dębinki 2, 80-211 Gdańsk, Poland

Received 14 January 2014; Revised 28 April 2014; Accepted 1 May 2014; Published 2 June 2014

Academic Editor: Elaine Hatanaka

Copyright © 2014 Jolanta Myśliwska et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Leijon, B. Hammarstrom, and D. Holmberg, “Non-obese diabetic (NOD) mice display enhanced immune responses and prolonged survival of lymphoid cells,” International Immunology, vol. 6, no. 2, pp. 339–345, 1994. View at Google Scholar · View at Scopus
  2. G. M. Brodie, M. Wallberg, P. Santamaria, F. S. Wong, and E. A. Green, “B-cells promote intra-islet CD8+ cytotoxic T-cell survival to enhance type 1 diabetes,” Diabetes, vol. 57, no. 4, pp. 909–917, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. A. M. Joussen, S. Doehmen, M. L. Le et al., “TNF-α mediated apoptosis plays an important role in the development of early diabetic retinopathy and long-term histopathological alterations,” Molecular Vision, vol. 15, pp. 1418–1428, 2009. View at Google Scholar · View at Scopus
  4. D.-S. Jung, S. H. Lee, S.-J. Kwak et al., “Apoptosis occurs differentially according to glomerular size in diabetic kidney disease,” Nephrology Dialysis Transplantation, vol. 27, no. 1, pp. 259–266, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. W. M. Kühtreiber, T. Hayashi, E. A. Dale, and D. L. Faustman, “Central role of defective apoptosis in autoimmunity,” Journal of Molecular Endocrinology, vol. 31, no. 3, pp. 373–399, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. P. I. Ingaramo, M. T. Ronco, D. E. A. Francés et al., “Tumor necrosis factor alpha pathways develops liver apoptosis in type 1 diabetes mellitus,” Molecular Immunology, vol. 48, no. 12-13, pp. 1397–1407, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. S. D. Tennenberg, R. Finkenauer, and A. Dwivedi, “Absence of lipopolysaccharide-induced inhibition of neutrophil apoptosis in patients with diabetes,” Archives of Surgery, vol. 134, no. 11, pp. 1229–1234, 1999. View at Google Scholar · View at Scopus
  8. F. Hanses, S. Park, J. Rich, and J. C. Lee, “Reduced neutrophil apoptosis in diabetic mice during staphylococcal infection leads to prolonged Tnfα production and reduced neutrophil clearance,” PLoS ONE, vol. 6, no. 8, Article ID e23633, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Yan, Y. Fu, and D. L. Faustman, “Reduced expression of Tap1 and Lmp2 antigen-processing genes in the nonobese diabetic (NOD) mouse due to a mutation in their shared bidirectional promoter,” Journal of Immunology, vol. 159, no. 6, pp. 3068–3080, 1997. View at Google Scholar · View at Scopus
  10. D. Faustman and M. Davis, “TNF receptor 2 pathway: drug target for autoimmune diseases,” Nature Reviews Drug Discovery, vol. 9, no. 6, pp. 482–493, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Guo, M. Li, Y. Zhang et al., “A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes,” Nature Genetics, vol. 36, no. 8, pp. 837–841, 2004. View at Google Scholar
  12. C.-Y. Wang, P. Yang, M. Li, and F. Gong, “Characterization of a negative feedback network between SUMO4 expression and NFκB transcriptional activity,” Biochemical and Biophysical Research Communications, vol. 381, no. 4, pp. 477–481, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. G. G. Song, S. J. Choi, J. D. Ji, and Y. H. Lee, “Association between the SUMO4 M55V (A163G) polymorphism and susceptibility to type 1 diabetes: a meta-analysis,” Human Immunology, vol. 73, no. 10, pp. 1055–1059, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. G. A. Limb, A. H. Chignell, W. Green, F. LeRoy, and D. C. Dumonde, “Distribution of TNFα and its reactive vascular adhesion molecules in fibrovascular membranes of proliferative diabetic retinopathy,” British Journal of Ophthalmology, vol. 80, no. 2, pp. 168–173, 1996. View at Google Scholar · View at Scopus
  15. E. Hatanaka, P. T. Monteagudo, M. S. M. Marrocos, and A. Campa, “Neutrophils and monocytes as potentially important sources of proinflammatory cytokines in diabetes,” Clinical and Experimental Immunology, vol. 146, no. 3, pp. 443–447, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Ramírez, J. Carracedo, A. Merino et al., “CD14+CD16+ monocytes from chronic kidney disease patients exhibit increased adhesion ability to endothelial cells,” Contributions to Nephrology, vol. 171, pp. 57–61, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Moriwaki, T. Inokuchi, A. Yamamoto et al., “Effect of TNF-α inhibition on urinary albumin excretion in experimental diabetic rats,” Acta Diabetologica, vol. 44, no. 4, pp. 215–218, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. A. M. Serra, J. Waddell, A. Manivannan, H. Xu, M. Cotter, and J. V. Forrester, “CD11b+ bone marrow-derived monocytes are the major leukocyte subset responsible for retinal capillary leukostasis in experimental diabetes in mouse and express high levels of CCR5 in the circulation,” American Journal of Pathology, vol. 181, no. 2, pp. 719–727, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Ziegler-Heitbrock, P. Ancuta, S. Crowe et al., “Nomenclature of monocytes and dendritic cells in blood,” Blood, vol. 116, no. 16, pp. e74–e80, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. A. M. Zawada, K. S. Rogacev, B. Rotter et al., “SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset,” Blood, vol. 118, no. 12, pp. e50–e61, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. K. L. Wong, W. H. Yeap, J. J. Y. Tai, S. M. Ong, T. M. Dang, and S. C. Wong, “The three human monocyte subsets: implications for health and disease,” Immunologic Research, vol. 53, no. 1—3, pp. 41–57, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Myśliwska, M. Smardzewski, N. Marek-Trzonkowska, M. Myśliwiec, and K. Raczyńska, “Expansion of CD14+CD16+ monocytes producing TNF-α in complication-free diabetes type 1 juvenile onset patients,” Cytokine, vol. 60, no. 1, pp. 309–317, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. N. A. Skinner, C. M. MacIsaac, J. A. Hamilton, and K. Visvanathan, “Regulation of Toll-like receptor (TLR)2 and TLR4 on CD14 dimCD16+ monocytes in response to sepsis-related antigens,” Clinical and Experimental Immunology, vol. 141, no. 2, pp. 270–278, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Sánchez-Torres, G. S. García-Romo, A. Rivas-Carvalho, and G. Sánchez-Schmitz, “CD16+ and CD16- human blood monocyte subsets differentiate in vitro to dendritic cells with different abilities to stimulate CD4+ T cells,” International Immunology, vol. 13, no. 12, pp. 1571–1581, 2001. View at Google Scholar · View at Scopus
  25. P. Ancuta, J. Wang, and D. Gabuzda, “CD16+ monocytes produce IL-6, CCL2, and matrix metalloproteinase-9 upon interaction with CX3CL1-expressing endothelial cells,” Journal of Leukocyte Biology, vol. 80, no. 5, pp. 1156–1164, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. K.-U. Belge, F. Dayyani, A. Horelt et al., “The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF,” Journal of Immunology, vol. 168, no. 7, pp. 3536–3542, 2002. View at Google Scholar · View at Scopus
  27. J. L. Mobley, M. Leininger, S. Madore, T. J. Baginski, and R. Renkiewicz, “Genetic evidence of a functional monocyte dichotomy,” Inflammation, vol. 30, no. 6, pp. 189–197, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. American Diabetes Association, “Diagnosis and classification of diabetes mellitus,” Diabetes Care, vol. 27, supplement 1, pp. S55–S60, 2008. View at Google Scholar
  29. P.-L. Chen and A. Easton, “Apoptotic phenotype alters the capacity of tumor necrosis factor-related apoptosis-inducing ligand to induce human vascular endothelial activation,” Journal of Vascular Research, vol. 45, no. 2, pp. 111–122, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. S. A. Renshaw, J. S. Parmar, V. Singleton et al., “Acceleration of human neutrophil apoptosis by TRAIL,” Journal of Immunology, vol. 170, no. 2, pp. 1027–1033, 2003. View at Google Scholar · View at Scopus
  31. T. P. Mikołajczyk, J. E. Skrzeczyńska-Moncznik, M. A. Zarębski et al., “Interaction of human peripheral blood monocytes with apoptotic polymorphonuclear cells,” Immunology, vol. 128, no. 1, pp. 103–113, 2009. View at Google Scholar
  32. P. Secchiero, A. Gonelli, E. Carnevale et al., “Evidence for a proangiogenic activity of TNF-related apoptosis-inducing ligand,” Neoplasia, vol. 6, no. 4, pp. 364–373, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. L. Thommesen and A. Lægreid, “Distinct differences between TNF receptor 1- and TNF receptor 2-mediated activation of NFκB,” Journal of Biochemistry and Molecular Biology, vol. 38, no. 3, pp. 281–289, 2005. View at Google Scholar · View at Scopus
  34. R. Amann and B. A. Peskar, “Anti-inflammatory effects of aspirin and sodium salicylate,” European Journal of Pharmacology, vol. 447, no. 1, pp. 1–9, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Cazanave, N. Vadrot, M. Tinel et al., “Ibuprofen administration attenuates serum TNF-α levels, hepatic glutathione depletion, hepatic apoptosis and mouse mortality after Fas stimulation,” Toxicology and Applied Pharmacology, vol. 231, no. 3, pp. 336–343, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. E. Ibeas, L. Fuentes, R. Martín, M. Hernández, and M. L. Nieto, “Inflammatory protein sPLA2-IIA abrogates TNFα-induced apoptosis in human astroglioma cells: crucial role of ERK,” Biochimica et Biophysica Acta, vol. 1793, no. 12, pp. 1837–1847, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Dreschers, C. Gille, M. Haas et al., “Infection-induced Bystander-Apoptosis of Monocytes is TNF-alpha-mediated,” PLoS ONE, vol. 8, no. 1, article e53589, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. A. M. Joussen, V. Poulaki, N. Mitsiades et al., “Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression,” The FASEB Journal, vol. 16, no. 3, pp. 438–440, 2002. View at Google Scholar · View at Scopus
  39. L. Mastrandrea, J. Yu, T. Behrens et al., “Etanercept treatment in children with new-onset type 1 diabetes: pilot randomized, placebo-controlled, double-blind study,” Diabetes Care, vol. 32, no. 7, pp. 1244–1249, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Migliore, U. Massafra, E. Carloni et al., “TNF-alpha blockade induce clinical remission in patients affected by polymyalgia rheumatica associated to diabetes mellitus and/or osteoporosis: a seven cases report,” European Review for Medical and Pharmacological Sciences, vol. 9, no. 6, pp. 373–378, 2005. View at Google Scholar · View at Scopus
  41. P. P. Sfikakis, N. Markomichelakis, G. P. Theodossiadis, V. Grigoropoulos, N. Katsilambros, and P. G. Theodossiadis, “Regression of sight-threatening macular edema in type 2 diabetes following treatment with the anti-tumor necrosis factor monoclonal antibody infliximab,” Diabetes Care, vol. 28, no. 2, pp. 445–447, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. Y. Moriwaki, T. Inokuchi, A. Yamamoto et al., “Effect of TNF-α inhibition on urinary albumin excretion in experimental diabetic rats,” Acta Diabetologica, vol. 44, no. 4, pp. 215–218, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. I. Yamakawa, H. Kojima, T. Terashima et al., “Inactivation of TNF-α ameliorates diabetic neuropathy in mice,” American Journal of Physiology—Endocrinology and Metabolism, vol. 301, no. 5, pp. E844–E852, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. E. C. Ebert, “Infliximab and the TNF-α system,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 296, no. 3, pp. G612–G620, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. G. Zizzo, B. A. Hilliard, M. Monestier, and P. L. Cohen, “Efficient clearance of early apoptotic cells by human macrophages requires M2c polarization and MerTK induction,” Journal of Immunology, vol. 189, no. 7, pp. 3508–3520, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Rutella, G. Fiorino, S. Vetrano et al., “Infliximab therapy inhibits inflammation-induced angiogenesis in the mucosa of patients with crohn's disease,” American Journal of Gastroenterology, vol. 106, no. 4, pp. 762–770, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. E. Izquierdo, J. D. Cañete, R. Celis et al., “Immature blood vessels in rheumatoid synovium are selectively depleted in response to anti-TNF therapy,” PLoS ONE, vol. 4, no. 12, Article ID e8131, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. D. Min, B. Brooks, J. Wong et al., “Alterations in Monocyte CD16 in association with diabetes complications,” Mediators of Inflammation, vol. 2012, Article ID 649083, 10 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. A. M. Serra, J. Waddell, A. Manivannan, H. Xu, M. Cotter, and J. V. Forrester, “CD11b+ bone marrow-derived monocytes are the major leukocyte subset responsible for retinal capillary leukostasis in experimental diabetes in mouse and express high levels of CCR5 in the circulation,” American Journal of Pathology, vol. 181, no. 2, pp. 719–727, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. Y. Chen, Y. Hu, M. Lin et al., “Therapeutic effects of PPARα agonists on diabetic retinopathy in type 1 diabetes models,” Diabetes, vol. 62, no. 1, pp. 261–272, 2013. View at Publisher · View at Google Scholar · View at Scopus
  51. S. Rangasamy, P. G. McGuire, and A. Das, “Diabetic retinopathy and inflammation: novel therapeutic targets,” Middle East African Journal of Ophthalmology, vol. 19, no. 1, pp. 52–59, 2012. View at Publisher · View at Google Scholar · View at Scopus